Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models
Background
While immunotherapy has been highly successful for the treatment of some cancers, for others, the immune response to tumor antigens is weak leading to treatment failure. The resistance of tumors to checkpoint inhibitor therapy may be caused…